Skip to content

Chemed CHE Common Stock Shares Held In Employee Trust

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesHeldInEmployeeTrust.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's common stock shares held in employee trust.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's common stock shares held in employee trust?
Chemed (CHE) reported common stock shares held in employee trust of $2.3M in Q4 2025.
How has Chemed's common stock shares held in employee trust changed year-over-year?
Chemed's common stock shares held in employee trust increased by 4.5% year-over-year, from $2.2M to $2.3M.
What is the long-term trend for Chemed's common stock shares held in employee trust?
Over 5 years (2020 to 2025), Chemed's common stock shares held in employee trust has grown at a 0.0% compound annual growth rate (CAGR), from $2.3M to $2.3M.